An appeals court ruling that validated its fight against a deal by the gene-sequencing giant Illumina is a boost for the agency’s expansive antitrust strategy.
An appeals court ruling that validated its fight against a deal by the gene-sequencing giant Illumina is a boost for the agency’s expansive antitrust strategy.
Leave a Reply